20 (AIDX) EBT Margin (2025 - 2026)
20's (AIDX) quarterly EBT Margin came in at 593.68% in Q1 2026, down 45565.0% YoY from N/an in Q1 2025, and down 330.1% on a QoQ basis from 138.03% in Q1 2025.
20 (AIDX) EBT Margin (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of EBT Margin data on file, last reported at 593.68% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 18.32% |
| 10 | 20 | 5.55 Mn | 1.00 Mn | 304,727.00 | -205.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -593.68% |
| Mar 31, 2025 | -138.03% |